TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06351254

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sine sound waves
Description: Group A 8 participants will be given sine sound waves treatment with the frequency of 80 pulses on C1 vertebrae. Treatment session will be 6 session 3 times a week followed by 6 sessions 2 times a week.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kinesthetic exercises
Description: Kinesthetic exercises was conducted for GROUP 2 8 patients for 6 weeks. Before and after assessment was taken to track patient progress. Cervicocephalic kinesthetic sensibility tests were performed. The first test was Head-to-Neutral Head Position(NHP) repositioning test. In the second repositioning test is Head-toTarget repositioning tests.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sine sound waves plus kinesthetic exercises
Description: Group C 8 was given combine treatment of sine sound waves and kinesthetic exercises before and after measurement was taken.
Study: NCT05814107

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CT-996
Description: Capsule of CT-996
Study: NCT05871502

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Subcutaneous blood glucose monitoring device
Description: After signing the informed consent and before the start of the endovascular procedure, a subcutaneous blood glucose monitoring device will be implanted, which will be removed on day 15 (or at hospital discharge if this takes place before 15 days). This device will be selected from those currently available on the market, with CE marking, and with previous studies documenting its safety and feasibility for radiological procedures.
Study: NCT05164237

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nerve flossing technique
Description: subjects will receive NFT with conventional physical therapy modalities in the form of (splint and therapeutic exercises ) 3 sessions every week for 8 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: multimodal electrotherapy
Description: subjects will receive multimodal approach of electrotherapy (LLLT , US and IFC) with conventional physical therapy modalities in the form of ( splint and therapeutic exercises ) 3 sessions every week for 8 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercises
Description: subjects will receive with conventional physical therapy modalities only in the form of (splint and therapeutic exercises ) 3 sessions every week for 8 weeks.
Study: NCT06072651

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relative Reinforcing Value of Food
Description: Researcher gives child opportunity to press a button to earn three types of rewards: a high-reward food, a low-reward food, and a non-food reward.
Study: NCT05814107

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule of Placebo
Study: NCT04847518

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Kan Jang capsules
Description: One capsule contains a fixed combination of proprietary~* Andrographis paniculata Nees. herb, native extract, DER native 4,5-8,0 :1 260 mg (Diterpene lactones andrographolide and 14-deoxy, 11,12- didehydroadnrograholide) 15-20 mg~* Eleutherococcus senticosus (Rupr. et Maxim) Harms, root, native extract DER native 17-30:1 : 11.4 mg and other inactive excipients (Polycristalline cellulose, Magnesium stearate).

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsules
Description: Inactive excipients
Study: NCT06435689

Intervention type: OTHER
Intervention: Sampling
Description: Blood and surgical specimen sampling the day of surgery
Study: NCT05719012

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: UC-MSCs
Description: Intravenous injection three times with one-month interval
Study: NCT03098225

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy
Description: A high-voltage linear accelerator will be used and a cumulative radiation dose of 20 Gy will be delivered to each eye in 10 fractionated doses over a period of 2 weeks. All patients will be treated in both eyes.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone
Description: Methylprednisolone pulse therapy for 12 weeks as follows: 500 mg IV once weekly for 6 weeks, then 250 mg IV once weekly for a further 6 weeks. Cumulative dose 4.5 g.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: Methylprednisolone pulse therapy for 12 weeks as follows: 500 mg IV once weekly for 6 weeks, then 250 mg IV once weekly for a further 6 weeks. Cumulative dose 4.5 g.
Study: NCT05719012

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UC-MSCs
Description: Intravenous injection three times with one-month interval
Study: NCT06485063

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Reorganization
Description: It is a manual technique in which the therapist applies a manual sustained oblique load of 45° with subsequent shear load. In general, the technique is divided into two stages, the first when the oblique load is accompanied by a passive shear load (applied by the therapist) during 1minute, and the second stage, when the shear oblique manual load is maintained but the shear load provoked by the participants' active movement (active shear load) during 1minute.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO Myofascial Reorganization
Description: it is light touch to the skin applied by the therapist, without provoking compression, or any constant or shear load during the fist minute. In the second minute, the participant adds active movements to the light touch. This two stage (each one during 1minute) is constructed to mimic the passive and the active stages of the real myofascial reorganization technique.
Study: NCT04216927

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitric Oxide
Description: gNO will be entrained at 20 ppm into the oxygenator of the CPB circuit

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oxygen
Description: Oxygen alone will be entrained for placebo arm
Study: NCT05465265

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Navigation into prEP by use of PrEP-UP intervention (provision of PrEP information through 5 counselling sessions, peer support, booking of appointments for PWIDs)
Description: Cases: Navigation of PWID into PrEP-Navigation into prEP by use of PrEP-UP intervention (provision of PrEP information through 5 counselling sessions, peer support, booking of appointments for PWIDs) Control group: Provision of PrEP information to PWID through pamphlets on PrEP uptake, adherence and retention among PWID.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Navigation into prEP by use of PrEP-UP intervention (provision of PrEP information through 5 counselling sessions, peer support, booking of appointments for PWIDs)
Description: Cases: Navigation of PWID into PrEP-Navigation into prEP by use of PrEP-UP intervention (provision of PrEP information through 5 counselling sessions, peer support, booking of appointments for PWIDs) Control group: Provision of PrEP information to PWID through pamphlets on PrEP uptake, adherence and retention among PWID.
Study: NCT05744349

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: K-wires Fixation of Pediatric Shaft Both Bone Forearm Fractures
Description: After administration of anesthesia, surgery will be performed with the patient supine on the operating table and fracture will be analyzed with an image intensifier. In radius, the wire will be inserted by surgical drilling through Lister's tubercle or the radial styloid while in ulna, the wire will be inserted through the tip of the olecranon.
Study: NCT05347316

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: 0.5 mg per day colchicine for 12 months
Study: NCT04991571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan (Treatment A)
Description: Zibotentan capsule will be administered orally as multiple doses in Part 1 and as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan (Treatment A)
Description: Zibotentan capsule will be administered orally as multiple doses in Part 1 and as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan (Treatment A)
Description: Zibotentan capsule will be administered orally as multiple doses in Part 1 and as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan (Treatment A)
Description: Zibotentan capsule will be administered orally as multiple doses in Part 1 and as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Treatment A)
Description: Dapagliflozin tablet will be administered orally as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Treatment A)
Description: Dapagliflozin tablet will be administered orally as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Treatment A)
Description: Dapagliflozin tablet will be administered orally as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan/Dapagliflozin - Formulation 1 (Treatment B)
Description: Zibotentan/Dapagliflozin tablet will be administered orally as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan/Dapagliflozin - Formulation 1 (Treatment B)
Description: Zibotentan/Dapagliflozin tablet will be administered orally as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan/Dapagliflozin - Formulation 1 (Treatment B)
Description: Zibotentan/Dapagliflozin tablet will be administered orally as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan/Dapagliflozin - Formulation 2 (Treatment C)
Description: Zibotentan/Dapagliflozin tablet will be administered orally as single dose in Part 2.
Study: NCT05692245

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron
Description: Administered Medication

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Administered Medication
Study: NCT06204107

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-379(Empagliflozin+sitagliptin+metformin) Test drug
Description: oral, once

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-379(Empagliflozin+sitagliptin+metformin) Test drug
Description: oral, once

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug
Description: oral, once

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug
Description: oral, once
Study: NCT04778475

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Description: PT services twice a day for 3-5 days and then daily for the remainder of hospital stay

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care therapy
Description: PT services 3-5 times a week for 15 to 30 minutes
Study: NCT05966948

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose Solution
Description: Prolotherapy is a regenerative tissue therapy that is considered efficacious for reducing the symptoms and morbidity of Knee Osteoarthritis (KOA) using hypertonic dextrose as an injectable substance. Treatment will be given two times, on day 1st and 30th day.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Normal Saline will be intra-articular injected and given two times, on day 1st and 30th day.
Study: NCT05049265

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JS007
Description: JS007 only
Study: NCT06222528

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief video intervention (Black Girl)
Description: A brief social contact-based video. The video presented a young Black girl, a professional actor, sharing her scripted personal story of struggles with depression and raising themes of recovery and hope.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief video intervention (Black Boy)
Description: A brief social contact-based video. The video presented a young Black boy, a professional actor, sharing his scripted personal story of struggles with depression and raising themes of recovery and hope.
Study: NCT04991571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan/Dapagliflozin - Formulation 2 (Treatment C)
Description: Zibotentan/Dapagliflozin tablet will be administered orally as single dose in Part 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan/Dapagliflozin - Formulation 2 (Treatment C)
Description: Zibotentan/Dapagliflozin tablet will be administered orally as single dose in Part 2.
Study: NCT06222528

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief video intervention (Latinx Girl)
Description: A brief social contact-based video. The video presented a young Latinx girl, a professional actor, sharing her scripted personal story of struggles with depression and raising themes of recovery and hope.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief video intervention (Latinx Boy)
Description: A brief social contact-based video. The video presented a young Latinx boy, a professional actor, sharing his scripted personal story of struggles with depression and raising themes of recovery and hope.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief video intervention (White Girl)
Description: A brief social contact-based video. The video presented a young White girl, a professional actor, sharing her scripted personal story of struggles with depression and raising themes of recovery and hope.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief video intervention (White Boy)
Description: A brief social contact-based video. The video presented a young White boy, a professional actor, sharing his scripted personal story of struggles with depression and raising themes of recovery and hope.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief video intervention (Nonbinary or transgender)
Description: A brief social contact-based video. The video presented a young nonbinary or transgender adolescent, a professional actor, sharing their scripted personal story of struggles with depression and raising themes of recovery and hope.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Condition
Description: A video that will provide information about depression and how to seek help but does not include a personal story.
Study: NCT05852860

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinician Nudge
Description: The clinician nudge will use the BPA functionality within the electronic medical record to deliver a message with a defaulted option to refer to the health system's tobacco treatment program. Changing the default to no referral will require an explanation using the options provided or by entering free text.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinician Nudge
Description: The clinician nudge will use the BPA functionality within the electronic medical record to deliver a message with a defaulted option to refer to the health system's tobacco treatment program. Changing the default to no referral will require an explanation using the options provided or by entering free text.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Nudge
Description: The patient nudge will deliver a message within 72 hours of a patient's next scheduled clinic visit. The message will be delivered through the Penn patient portal (MyPennMedicine) or by text with security measures for privacy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Nudge
Description: The patient nudge will deliver a message within 72 hours of a patient's next scheduled clinic visit. The message will be delivered through the Penn patient portal (MyPennMedicine) or by text with security measures for privacy.
Study: NCT05582174

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: Vonoprazan 40 mg bid orally for 72 hours, and from day 4-30 VPZ 20 mg daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: esomeprazole
Description: A high dose PPI infusion (esomeprazole 80mg iv bolus followed by 8mg per hour for 72 hours), and frorm day 4-30 oral esomeprazole daily
Study: NCT06238804

Intervention type: PROCEDURE
Intervention: KL, Iliofemoral, Ilioinguinal, Iliac fossa and combined approaches
Description: A3.1, A3.2, A3.3
Study: NCT06464263

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: to investigate the postoperative analgesic-sedative effect of dexmedetomidine versus fentanyl-midazolam to achieve fast-track extubation after adult valvular cardiac surgeries.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: to investigate the postoperative analgesic-sedative effect of dexmedetomidine versus fentanyl-midazolam to achieve fast-track extubation after adult valvular cardiac surgeries.
Study: NCT06201286

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Concept
Description: Mulligan Concept was applied by the physiotherapist who received A-B module trainings. Mulligan techniques were performed with 3 sets of 10 repetitions and 15-20 seconds rest between sets. Mobilisations were applied to the spinous process of each vertebra of the lumbar region with 3 sets of 10 repetitions of SNAG and 3 sets of 10 repetitions of NAGS techniques. In the standing position, the physiotherapist took a position next to the patient and stabilised the patient by grasping the abdomen with one arm.~Strengthening exercises were applied to the rectus abdominis, internal and external obliquus, transversus abdominis muscles from flexor muscle groups in 3 sets of 10 repetitions. Stretching exercises were applied to the erector spinae and intertransversarii lumborum muscles from extensor muscle groups as 3 sets of 10 repetitions for 15-30 seconds.

Intervention type: OTHER
Group type: OTHER
Intervention: Stretching and strengthening exercises
Description: Strengthening exercises were applied to the rectus abdominis, internal and external obliquus, transversus abdominis muscles from flexor muscle groups in 3 sets of 10 repetitions. Stretching exercises were applied to the erector spinae and intertransversarii lumborum muscles from extensor muscle groups as 3 sets of 10 repetitions for 15-30 seconds.
Study: NCT05928052

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Biopac Electrical Stimulator
Description: A transcutaneous electrical stimulator sends low levels of electrical current through surface hydrogel electrodes directly to the spinal cord to improve function.
Study: NCT06208995

Intervention type: OTHER
Intervention: 36-Item Short Form Survey Instrument (SF-36)
Description: Answering 36 questions in a quality-of-life survey (RAND 36-Item Health Survey 1.0): https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/survey-instrument.html
Study: NCT05755984

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 3D printed model
Description: scan
Study: NCT05284838

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Error Management Training (Difficult)
Description: Error Management Training is used to teach head computed tomography interpretation. Participants encounter difficult questions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Error Management Training (Easy)
Description: Error Management Training is used to teach head computed tomography interpretation. Participants encounter easy questions.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Error Avoidance Training
Description: Error Avoidance Training used to teach head computed tomography interpretation.
Study: NCT05963997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Samuraciclib
Description: Samuraciclib capsules by mouth once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Samuraciclib
Description: Samuraciclib capsules by mouth once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Samuraciclib
Description: Samuraciclib capsules by mouth once a day
Study: NCT04646499

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation
Description: Transcranial alternating current stimulation (tACS) will be applied at 40 Hz (gamma band) during eight sessions over the course of a month.
Study: NCT05963997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Samuraciclib
Description: Samuraciclib capsules by mouth once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elacestrant Dihydrochloride
Description: Elacestrant tablets by mouth once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elacestrant Dihydrochloride
Description: Elacestrant tablets by mouth once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elacestrant Dihydrochloride
Description: Elacestrant tablets by mouth once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elacestrant Dihydrochloride
Description: Elacestrant tablets by mouth once a day
Study: NCT04985669

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prucalopride 2mg
Description: one group of patient will receive prucalopride once daily one group of patient will receive lubiprostone twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prucalopride 2mg
Description: one group of patient will receive prucalopride once daily one group of patient will receive lubiprostone twice daily
Study: NCT05014685

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Description: 20mg bid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Description: 20mg bid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabeprazole
Description: 20mg bid
Study: NCT05516082

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens A
Description: DDH contact lens for 15 minutes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens B
Description: DDSH contact lens for 15 minutes
Study: NCT05014685

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Description: 20mg bid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bismuth potassium citrate
Description: 0.6g bid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth potassium citrate
Description: 0.6g bid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole
Description: 0.4g tid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: 0.4g tid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: 1g tid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: 1g tid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: 1g tid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: 1g tid